Picture of Ashland logo

ASH — Ashland News Story

0.000.00%
us flag iconLast trade - 00:00
Basic MaterialsBalancedLarge CapNeutral

Ashland Q1 revenue misses expectations, hurt by Avoca divestiture

Overview

Global additives firm's Q1 revenue fell 5% yr/yr, missing analyst expectations

Adjusted EBITDA for Q1 declined 5%, impacted by Avoca divestiture and Calvert City outage

Company narrowed full-year fiscal 2026 adjusted EBITDA guidance due to temporary impacts

Outlook

Ashland narrows full-year fiscal 2026 Adjusted EBITDA guidance to $400 mln–$420 mln

Company expects resilient demand in Life Sciences and Personal Care

Specialty Additives markets remain mixed; coatings recovery expected to be uneven

Result Drivers

AVOCA DIVESTITURE - Reduced sales and adjusted EBITDA by 2%, with a 3% decline excluding this impact

CALVERT CITY OUTAGE - Negatively impacted adjusted EBITDA by approximately $10 million

SPECIALTY ADDITIVES CHALLENGES - Weak demand in coatings and construction markets affected sales

Key Details

MetricBeat/MissActualConsensus Estimate
Q1 RevenueMiss$386 mln$402.01 mln (8 Analysts)
Q1 EPS-$0.26
Q1 Net Income-$12 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell" The average consensus recommendation for the diversified chemicals peer group is "buy" Wall Street's median 12-month price target for Ashland Inc is $67.65, about 10.6% above its January 30 closing price of $61.16 The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 11 three months ago Press Release: ID:nGNX88tc3Q For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Ashland

See all news